Pasmol Pain Relieving

Medically reviewed by Drugs.com. Last updated on Mar 29, 2021.

Dosage form: cream
Ingredients: MENTHOL 5g in 100g, METHYL SALICYLATE 14g in 100g
Labeler: Grafor, Inc.
NDC Code: 61361-820

Pasmol Pain Relieving Ointment

Active ingredients

Menthol 5%

Methyl Salicylate 14%

Purpose

Pain Relieving

Uses

For the temporary relief of minor aches and pains of the muscles and joints associated with:

Arthritis
simple backache
bruises
sprains

Warnings

For external use only.

Do not use

in the eyes
on mucous membranes
on wounds or damaged skin

When using this product

do not bandage tightly

Stop use and ask a doctor if

condition worsens or symptoms persist for more than 7 days or clear up and occur again within a few day
redness is present
excessive irritation of the skin develops

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Adults and children three years of age and older: apply to affected area not more than 3-4 times daily.
Children under 3 years of age: consult a doctor

Inactive ingredients

PETROLATUM

MANUFACTURED BY GRAFOR INC. 1360 CASTELLANAS ST LA RAMBLA PONCE, PR 00730 UNITED STATES (787) 842-1423 WWW.PASMOL.COM REPORT ADVERSE EVENTS TO GRAFOR INC.

Pasmol Pain Relieving Ointment, 85g (61361-820-03)

PASMOL

“Arthritis Formula”

“Formula Artritis”

Pain Relieving Ointment

Net Wt./ Peso Neto 3 oz (85 g)

PASMOL PAIN RELIEVING
menthol and methyl salicylate cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:61361-820
Route of Administration	TOPICAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
MENTHOL (MENTHOL)	MENTHOL	5 g in 100 g
METHYL SALICYLATE (SALICYLIC ACID)	METHYL SALICYLATE	14 g in 100 g

Inactive Ingredients
Ingredient Name	Strength
PETROLATUM

Packaging
#	Item Code	Package Description
1	NDC:61361-820-03	85 g in 1 JAR

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC MONOGRAPH NOT FINAL	part348	04/08/2015